Scientists probe why cancer drugs turn body against itself
NCT ID NCT04119713
Summary
This study aims to understand why some cancer patients develop autoimmune conditions as a side effect of immunotherapy drugs called checkpoint inhibitors. Researchers will observe 600 cancer patients who are prescribed these drugs, collecting blood samples to study their immune systems. The goal is to identify genetic and immune factors that predict who might experience these side effects, but no treatments or interventions are being tested.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ONCOLOGY are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
University of Pennsylvania - Abramson Cancer Center
RECRUITINGPhiladelphia, Pennsylvania, 19104, United States
Contact
Conditions
Explore the condition pages connected to this study.